The National Academy of Sciences, National Academy of Medicine, Chinese Academy of Sciences, and the Royal Society of the UK organized an International Summit in Washington, D.C., in December 2015 on recent scientific developments in human gene editing and the range of ethical and governance issues associated with these advances.
The meeting considered issues such as the current state of the science and available technologies; the rationale(s) for and potential benefits and risks inherent in conducting such research and in potential applications; existing (as well as potentially needed) regulatory principles, standards, or guidance for such research and potential applications; ethical concerns; legal considerations; and ways to engage critical stakeholders. An ad hoc committee, chaired by CSTL Co-chair David Baltimore, organized the meeting. The meeting consisted of invited presentations and discussions and included participation from experts from countries with significant research underway or being launched on human gene editing.
This activity was part of a larger National Academies' Human Gene Editing Initiative.
This website contains unedited verbatim presentations made by meeting participants as well as individually authored papers. Neither are official reports of the National Academies of Sciences, Engineering, and Medicine. Opinions and statements included in these materials are solely those of the individual authors. They have not been verified as accurate, nor do they necessarily represent the views of other participants, the committee, or the National Academies.
International Summit on Human Gene Editing: A Global Discussion
December 1-3, 2015
View Video of Day 1
View Video of Day 2
View Video of Day 3
Presenter slides may be found here.
Read commissioned papers based on summit presentations.
Information Gathering Meeting for the Planning Committee Organizing the International Summit on Human Gene Editing
October 5, 2015
On December 3, 2015, the summit organizing committee issued a statement on human gene-editing research and its potential applications. Read the statement as well as a response from the presidents of the four summit co-hosts.
A meeting in brief summarizing the summit proceedings was released on February 1, 2016.
David Baltimore (NAS/NAM)
President Emeritus and Robert Andrews Millikan Professor of Biology
California Institute of Technology
Professor and Canada Research Chair in Bioethics and Philosophy
Paul Berg (NAS/NAM)
Robert W. and Vivian K. Cahill Professor Emeritus and Director Emeritus
Beckman Center for Molecular and Genetic Medicine
Stanford University School of Medicine
George Q. Daley (NAM)
Samuel E. Lux IV Professor of Hematology/Oncology
Director, Stem Cell Transplantation Program
Boston Children's Hospital and Dana-Farber Cancer Institute
Jennifer A. Doudna (NAS/NAM)
Investigator, Howard Hughes Medical Institute
Professor, Department of Molecular and Cell Biology, Lawrence Berkeley National Laboratory and Department of Chemistry University of California, Berkeley
Eric S. Lander (NAS/NAM)
President and Director
The Broad Institute of Harvard and MIT
Group Leader and Head
Division of Stem Cell Biology and Developmental Genetics
The Francis Crick Institute
Professor of Law and Bioethics
University of Wisconsin
Morgridge Institute for Research
Professor and Director General
Guangzhou Institutes of Biomedicine and Health
Chinese Academy of Sciences
Professor of Paediatric Immunology
University College London
Ernst-Ludwig Winnacker (NAM)
Professor Emeritus and Director Emeritus
Professor and Deputy Director
Institute of Zoology
Chinese Academy of Sciences
This project is sponsored by the National Institutes of Health, the Burroughs Wellcome Fund, the Wellcome Trust, and the W.K. Kellogg Foundation Fund.